Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:33 PM ET 8-K
Financial Results Lument Finance Trust, Inc. LFT

Lument Finance Trust Financial Results

Lument Finance Trust reported its third quarter 2026 financial results, posting a GAAP net loss of $13.5 million, or $2.57 per share. The company also reported a non-GAAP Distributable Loss of $0.7 million, or $0.13 per share, for the period ended September 30, 2026.

Term
Q3 2026
6:33 PM ET 8-K
Loan & Debt Epr Properties EPR

Epr Properties $575M Debt Financing with U.S. Bank Trust Company, National Association

EPR Properties closed a private offering of $575.0 million in 4.5% Convertible Senior Notes due 2032, which included the full exercise of a $75.0 million overallotment option. The company used the proceeds to fund capped call transactions, repurchase $50.0 million of its common shares, and intends to repay $450.0 million of existing 4.750% Senior Notes maturing in December 2026.

Value
$575M
Counterparty
U.S. Bank Trust Company, National Association
Term
through Feb 2032
6:33 PM ET 8-K
Loan & Debt Moderna, Inc. MRNA

Moderna $900M Debt Financing with Ares Capital Corporation

Moderna entered into an amendment to its existing Credit and Guaranty Agreement with Ares Capital Corporation, reducing interest rate margins by 0.75 percentage points and extending the maturity date to November 24, 2031. The amendment also extends the availability period for $900 million in delayed draw term loan commitments through November 2029.

Value
$900M
Counterparty
Ares Capital Corporation
Term
through Nov 2031
6:33 PM ET 10-Q
Financial Results Metech Group Inc. MEGR

Metech Group Q3 2026 Results: Net Income $303K, Up 41.8% YoY

Metech Group Inc. reported a significant increase in net income to $1,083,316 for the nine months ended September 30, 2026, compared to $501,013 in the prior year period, driven by a 18.4% growth in revenues. The company successfully alleviated its going concern doubt due to recent profitability and financial support from significant shareholders.

Key figure
Net income $303K · +41.8% YoY
6:33 PM ET 10-Q
Financial Results Stark Novus Financial Inc.

Stark Novus Financial Q3 2026 Results: Net Loss of $2.52M

Stark Novus Financial Inc. reported a net loss of $2.5 million for the quarter ended September 30, 2026, as it transitioned into insurance and wealth management services following its reorganization. The company's balance sheet shows a shift from a positive stockholders' equity of $2.6 million at the end of 2025 to a deficit of $2.3 million by September 2026.

Key figure
Net loss $2.52M
6:33 PM ET 10-Q
Financial Results Limitless X Holdings Inc.

Limitless X Holdings Q3 2026 Results: Net Loss of $2.34M, Loss Narrows

Limitless X Holdings Inc. reported a significant decline in net revenue to $143,399 for the nine months ended September 30, 2026, compared to $802,396 in the prior year. The company incurred a net loss of $34,096,665 during this period, driven largely by a $27.8 million loss on the conversion of Preferred C to Preferred D stock and high salary expenses.

Key figure
Net loss $2.34M
6:33 PM ET 10-Q
Financial Results Feel The World, Inc.

Feel The World Q3 2026 Results: Turns Profitable, Net Income $1.07M

Feel The World, Inc. reported a significant turnaround for the nine months ended September 30, 2026, with net income of $2.15 million compared to a net loss of $1.91 million in the prior year period. Revenue grew to $50.69 million, driven by improved gross margins and operational efficiencies, despite an accumulated deficit of $4.28 million.

Key figure
Net income $1.07M
6:33 PM ET 10-Q
Financial Results TruGolf Holdings, Inc. TRUG

TruGolf Holdings Q3 2026 Results: Net Loss of $2.08M, Loss Narrows

TruGolf Holdings reported a net loss of $3.98 million for the nine months ended September 30, 2026, a significant improvement from the $13.27 million loss in the prior year period. Revenue grew 16.8% to $16.13 million, while the company's stockholders' equity shifted to a deficit of $22,716 as of the end of the quarter.

Key figure
Net loss $2.08M
6:33 PM ET 10-Q
Financial Results Tevogen Inc. TVGN

Tevogen Q3 2026 Results: Net Loss of $7M, Loss Widens

Tevogen Inc. reported a net loss of $18.2 million for the nine months ended September 30, 2026, compared to $21.6 million in the prior year period. The company continues to operate with a significant stockholders' deficit of $11.3 million and relies on financing activities, including a $3.0 million loan and $3.0 million from pre-funded warrants, to fund its biotechnology and AI initiatives.

Key figure
Net loss $7M
6:33 PM ET 10-Q
Financial Results Lightstone Value Plus REIT III, Inc.

Lightstone Value Plus REIT III Q3 2026 Results: Net Loss of $4.34M

Lightstone Value Plus REIT III reported a net loss of $7.2 million for the nine months ended September 30, 2026, compared to a $3.3 million loss in the prior year, primarily driven by a $4.6 million impairment charge. Total assets decreased to $110.8 million from $117.2 million at year-end 2025, while total equity declined to $46.7 million due to the net loss and share redemptions.

Key figure
Net loss $4.34M
6:33 PM ET 10-Q
Financial Results Integrated Rail & Resources Inc.

Integrated Rail & Resources Q3 2026 Results: Net Income $2.02M, Down 66.3% YoY

Integrated Rail & Resources Inc. reported a net income of $685,749 for the nine months ended September 30, 2026, a significant recovery from a net loss of $5,562,621 in the prior year period, primarily driven by a $5.8 million gain from the change in fair value of warrant liabilities. Despite the net profit, the company maintains a stockholders' deficit of $16.2 million and notes substantial doubt about its ability to continue as a going concern as it works toward a 2028 facility in-service date.

Key figure
Net income $2.02M · -66.3% YoY
6:33 PM ET 10-Q
Financial Results Beneficient BENF

Beneficient Q2 2026 Results: Net Loss of $22.1M, Loss Widens

Beneficient reported a net loss of $39.4 million for the quarter ended September 30, 2026, compared to a loss of $17.9 million in the prior year period. Total assets decreased to $227.3 million from $238.8 million at fiscal year-end, while the company's accumulated deficit grew to $2.12 billion.

Key figure
Net loss $22.1M
6:32 PM ET 10-Q
Financial Results Vivos Therapeutics, Inc. VVOS

Vivos Therapeutics Q3 2026 Results: Net Loss of $1.95M, Loss Narrows

Vivos Therapeutics is transitioning from a legacy dentist-focused model to a medical-provider focused sales and distribution model, highlighted by the acquisition of The Sleep Center of Nevada and a transaction with SOD Sciences. The company faces significant challenges regarding its Nasdaq listing requirements and the integration of its new business model while managing substantial indebtedness.

Key figure
Net loss $1.95M
6:32 PM ET 10-Q
Financial Results Global Macro Trust

Global Macro Trust Q3 2026 Results: Turns Profitable, Net Income $3.03M

For the nine months ended September 30, 2026, Global Macro Trust reported a significant turnaround with a net income of $8,596,407 compared to a net loss of $3,561,629 in the prior year period. This performance was driven by $9,247,519 in total net realized and unrealized gains, primarily from futures and forward currency contracts, which offset a net investment loss of $636,505.

Key figure
Net income $3.03M
6:32 PM ET 10-Q
Financial Results Super League Enterprise, Inc. SLE

Super League Enterprise Q3 2026 Results: Net Loss of $2.88M, Loss Narrows

Super League Enterprise reported a net loss of $11.3 million for the nine months ended September 30, 2026, compared to $10.6 million in the prior year period, despite a 6% increase in revenue to $8.6 million. The company's balance sheet shows a significant decrease in cash and cash equivalents from $14.4 million at year-end 2025 to $4.4 million as of September 30, 2026.

Key figure
Net loss $2.88M
6:32 PM ET 10-Q
Financial Results Mangoceuticals, Inc. MGRX

Mangoceuticals Q3 2026 Results: Net Loss of $3.55M, Loss Narrows

Mangoceuticals, Inc. is a smaller reporting company and emerging growth company focused on scaling its operations and marketing its products. The filing highlights significant risks including a limited operating history, the need for additional funding, and reliance on third-party compounding pharmacies for products not approved by the FDA.

Key figure
Net loss $3.55M
6:32 PM ET 10-Q
Financial Results CDT Equity Inc. CDT

CDT Equity Q3 2026 Results: Net Loss of $4.58M, Loss Narrows

CDT Equity Inc. reported a net loss of $13.3 million for the nine months ended September 30, 2026, compared to $17.9 million in the prior year. The company significantly expanded its balance sheet through a $153.5 million equity method investment, resulting in total assets increasing from $5.7 million to $158.7 million.

Key figure
Net loss $4.58M
6:32 PM ET 10-Q
Financial Results Blusky AI Inc.

Blusky AI Q3 2026 Results: Net Loss of $569K, Loss Narrows

BluSky AI Inc. reported a net loss of $1,476,476 for the nine months ended September 30, 2026, compared to a net loss of $4,014,763 in the prior year period. The company remains in a stockholders' deficit position of $787,655, though it successfully raised $1,910,966 through common stock issuances during the period.

Key figure
Net loss $569K
6:32 PM ET 10-Q
Financial Results Longduoduo Co Ltd

Longduoduo Co Q1 2026 Results: Net Loss of $437K, Loss Widens

Longduoduo Co Ltd reported a significant revenue decline to $17,595 for the quarter ended September 30, 2026, compared to $658,764 in the prior year, primarily due to a sharp drop in commission revenue. The company realized a net loss of $474,167 for the period and underwent a corporate restructuring involving the deregistration of its Hong Kong subsidiary.

Key figure
Net loss $437K
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution Executive VP and CMO Marco Cardazzi Buys $25.1K of Stock

Marco Cardazzi, Executive VP and CMO, bought 2,508 shares of Adi Global Distribution Inc. at $10.00 a share, worth $25.1K in total on Nov 13, 2026. Shares held after the trade: 12,917 (+24.1%).

Value
$25.1K
Shares
2,508
Price
$10.00
Role
Executive VP and CMO
Holding change
+24.1%
Trade date
Nov 13, 2026
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution President and CEO Robert B. Aarnes Buys $100K of Stock

Robert B. Aarnes, President and CEO, bought 10,073 shares of Adi Global Distribution Inc. at $9.93 a share, worth $100K in total on Nov 13, 2026. Shares held after the trade: 123,721 (+8.9%).

Value
$100K
Shares
10,073
Price
$9.93
Role
President and CEO
Holding change
+8.9%
Trade date
Nov 13, 2026
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution Exec. VP, GC, Corp. Sec. & CCO Jeannine J. Lane Buys $50.1K of Stock

Jeannine J. Lane, Exec. VP, GC, Corp. Sec. & CCO, bought 5,241 shares of Adi Global Distribution Inc. at $9.55 a share, worth $50.1K in total on Nov 16, 2026. Shares held after the trade: 86,133 (+6.5%).

Value
$50.1K
Shares
5,241
Price
$9.55
Role
Exec. VP, GC, Corp. Sec. & CCO
Holding change
+6.5%
Trade date
Nov 16, 2026
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution Executive VP, CFO Michael Carlet Buys $99.9K of Stock

Michael Carlet, Executive VP, CFO, bought 10,288 shares of Adi Global Distribution Inc. at $9.71 a share, worth $99.9K in total on Nov 13, 2026. Shares held after the trade: 50,623 (+25.5%).

Value
$99.9K
Shares
10,288
Price
$9.71
Role
Executive VP, CFO
Holding change
+25.5%
Trade date
Nov 13, 2026
6:32 PM ET Form 4
Insider Selling Covenant Logistics Group, Inc. CVLG

Covenant Logistics Group Chairman and CEO David Ray Parker Sells $5.66M of Stock

David Ray Parker, Chairman and CEO, sold 173,989 shares of Covenant Logistics Group, Inc. at $32.35 to $33.77 a share (average $32.54) in 4 transactions, worth $5.66M in total between Nov 12, 2026 and Nov 16, 2026. Shares held after the trade: 1,803,555 (-4.7%).

Value
$5.66M
Shares
173,989
Average price
$32.54
Role
Chairman and CEO
Holding change
-4.7%
Trade date
Nov 12, 2026 to Nov 16, 2026
6:32 PM ET 10-Q
Financial Results SDR Drone, Inc.

SDR Drone Q3 2026 Results: Net Loss of $182K, Loss Narrows

SDR Drone, Inc. reported a net loss of $598,438 for the nine months ended September 30, 2026, compared to a loss of $760,649 in the prior year period. The company remains in a development stage with zero revenue and a stockholders' deficit of $243,944, primarily driven by professional fees and non-cash expenses related to debt amortization and derivative liabilities.

Key figure
Net loss $182K
6:32 PM ET 10-Q
Financial Results ConnectM Technology Solutions, Inc.

ConnectM Technology Solutions Q3 2026 Results: Net Loss of $8.12M, Loss Widens

For the nine months ended September 30, 2026, ConnectM Technology Solutions reported revenues of $26.35 million, an increase from $24.31 million in the prior year. The company recorded a net loss attributable to stockholders of $2.32 million, significantly improved from a $12.18 million loss in 2025, primarily due to a $19.05 million gain on the disposal of discontinued operations.

Key figure
Net loss $8.12M
6:32 PM ET 10-Q
Financial Results Host Digital Inc. HOST

Host Digital Q3 2026 Results: Net Loss of $9.67M

Host Digital Inc. reported a net loss of $11.45 million for the eight months ended September 30, 2026, following a reverse acquisition and public offering in September 2026. The company generated $1.48 million in net sales during the period, while significantly expanding its balance sheet to $108.2 million in total assets, primarily through intangible assets and right-of-use assets.

Key figure
Net loss $9.67M
6:32 PM ET 10-Q
Financial Results Picard Medical, Inc. PMI

Picard Medical Q3 2026 Results: Net Loss of $2.22M, Loss Narrows

Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.

Key figure
Net loss $2.22M
6:32 PM ET 10-Q
Financial Results Cyabra, Inc. CYAB

Cyabra Q3 2026 Results: Net Loss of $2.59M, Loss Narrows

Cyabra, Inc. reported revenues of $5.27 million for the nine months ended September 30, 2026, compared to $4.08 million in the prior year period. The company experienced a significant net loss of $16.8 million, driven by increased research and development and general administrative expenses following a business combination and PIPE financing.

Key figure
Net loss $2.59M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.